Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from ABBV

3 Highest-Yielding Dividend Kings To Buy Today

Start your New Year early by exploring high-yield Dividend Kings with decades of growth, top analyst ratings, and attractive yields for long-term investors.

Barchart

3 High-Potential Dividend Growth Stocks for 2024

In times of market volatility, driven by geopolitical risks and political uncertainty, dividend growth stocks offer stability and reliable income. Hence, investing in Home Depot (HD), AbbVie (ABBV), and Lowe's Companies (LOW) stocks could be a wise choice for investors seeking long-term growth and consistent cash flow. Read more….

StockNews.com

Check Out What Whales Are Doing With ABBV

Financial giants have made a conspicuous bullish move on AbbVie. Our analysis of options history for AbbVie (NYSE:ABBV) revealed 10 unusual trades.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Is AbbVie Stock Underperforming the Dow?

AbbVie has underperformed the Dow over the past year, but analysts are moderately optimistic about the stock’s prospects.

Barchart

3 Healthcare ETFs for a Balanced Investment Approach

For investors seeking a balanced approach, healthcare ETFs offer a combination of stability and growth potential. Therefore, it might be wise to consider Fidelity MSCI Health Care Index ETF (FHLC), iShares U.S. Healthcare ETF (IYH), and Vanguard Health Care Index Fund ETF Shares (VHT) for a balanced approach. Keep reading….

StockNews.com

Check Out What Whales Are Doing With ABBV

Financial giants have made a conspicuous bullish move on AbbVie. Our analysis of options history for AbbVie (NYSE:ABBV) revealed 13 unusual trades.

Benzinga

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Don't Miss the Buying Opportunity in This Dividend King, Says Analyst

Leerink believes the recent selloff has made valuations attractive.

Barchart

Spotlight on AbbVie: Analyzing the Surge in Options Activity

Investors with a lot of money to spend have taken a bearish stance on AbbVie (NYSE:ABBV).

Benzinga

3 Healthcare Stocks Leading the Fight Against Global Diseases

As chronic and infectious diseases continue to rise, the demand for advanced healthcare solutions grows. Hence, investing in established healthcare stocks, Pfizer (PFE), Merck & Co (MRK), and AbbVie (ABBV), presents a compelling opportunity to capitalize on the sector’s landscape. Read on….

StockNews.com

Market Whales and Their Recent Bets on ABBV Options

Financial giants have made a conspicuous bearish move on AbbVie. Our analysis of options history for AbbVie (NYSE:ABBV) revealed 13 unusual trades.

Benzinga

3 Oversold Dividend Aristocrats Ready To Explode in 2025

These three companies all have one thing in common: they are all on sale.

Barchart

3 Dividend Powerhouses Yielding Over 3% to Consider

Dividend stocks are attractive for their steady income, stability, and growth potential, especially amid low interest rates and economic uncertainties. Against this backdrop, income-seeking investors may want to consider high-dividend stocks yielding over 3%, such as AbbVie (ABBV), Coca-Cola (KO), and AT&T (T). Keep reading.

StockNews.com

3 Dividend Growth Stocks for Long-Term Investors

Dividend growth stocks offer a unique blend of reliability and growth potential, making them an ideal choice for long-term investors. Therefore, you might consider watching stocks like The Home Depot (HD), AbbVie (ABBV), and McDonald's Corp (MCD) for long-term investments. Read on….

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Healthcare Stocks to Buy for the Aging Population Boom

The rapidly growing aging population is driving expansion in healthcare, with rising demand for treatments and chronic disease management. Companies like AbbVie (ABBV), Medtronic (MDT), and Centene (CNC) are well-positioned to meet these needs, making them attractive options for investors seeking to capitalize on the industry’s sustained growth potential. Read…

Barchart

Are Wall Street Analysts Bullish on AbbVie Stock?

Despite AbbVie’s outperformance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.

StockNews.com

3 Healthcare Stocks to Buy for an Aging Population Boom

As the global population ages, demand for healthcare solutions are expected to surge. As a result, investors might consider fundamentally solid healthcare stocks UnitedHealth Group, AbbVie, and Merck & Co., which are poised to benefit from the aging population boom. Keep reading.

Barchart

3 Undervalued Dividend Aristocrats Poised for Explosive Gains in 2025

Hunting for value? These three Dividend Aristocrats look cheap by today's valuations.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

AbbVie's Q3 2024 Earnings: What to Expect

With AbbVie gearing up to release its third-quarter earnings later this month, analysts expect a marginal decline in earnings.

Barchart

3 Highest-yielding Dividend Kings for Maximum Income and Stability

Looking for reliable yield? These three companies offer ever-increasing dividends and a lifetime of stability.

StockNews.com

3 Healthcare Stocks for Safe, Steady Growth

The healthcare industry is set for growth due to the growing demand for quality healthcare services and ongoing advancements in medical technology. Hence, investors might consider investing in healthcare stocks, Johnson & Johnson (JNJ), AbbVie (ABBV), and Thermo Fisher Scientific (TMO) for safe and steady growth. Read more….

StockNews.com

3 Pharmaceutical Stocks That Could Lead the Next Drug Revolution

The pharmaceutical industry is promising due to AI and biotech innovations enhancing productivity, steady profits amidst economic shifts, rising chronic illnesses, and strong growth projections in global revenues and biotechnology markets. Therefore, it could be wise to invest in pharma stocks such as AbbVie (ABBV), Bristol-Myers Squibb (BMY), and Gilead…

StockNews.com

3 Healthcare ETFs to Buy for Defensive Growth in 2024

Healthcare ETFs hold the potential for higher returns, diversification, and exposure to stably growing companies. Therefore, it could be wise to invest in robust healthcare ETFs like iShares U.S. Healthcare Providers ETF (IHF), Vanguard Health Care Index Fund ETF Shares (VHT), and Health Care Select Sector SPDR Fund (XLV) for…

StockNews.com

3 High-Dividend Pharma Blue Chips That Are on Sale Right Now

With the Federal Reserve potentially cutting interest rates for the first time in over four years, uncertainty looms in the market. Amid this backdrop, it could be wise to scoop up the shares of fundamentally sound pharma stocks like AbbVie (ABBV), Novartis (NVS), and Pfizer (PFE), which are not just…

StockNews.com

3 Healthcare Stocks Benefiting From Aging Populations

The healthcare industry is thriving, owing to the growing healthcare expenditure and aging population. Given the industry’s tailwinds, fundamentally sound healthcare stocks AbbVie (ABBV), Boston Scientific (BSX), and CVS Health (CVS) could be solid buys. Keep Reading….

1 … 3 4 5 6

People

Kritika SarmahHer

727 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.